Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03351855
What this trial is testing

HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV

Who this might be right for
Human Papilloma Virus
Shenzhen Geno-Immune Medical Institute 100
Early research (Phase 1)Active Not RecruitingNCT00368082
What this trial is testing

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

Who this might be right for
LymphomaHodgkin's DiseaseRelapse+1 more
Baylor College of Medicine 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02210078
What this trial is testing

Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 49
Not applicableStudy completedNCT03325400
What this trial is testing

Cytogenetic Damage in Buccal Cells Caused by Toothpaste

Who this might be right for
Toxicity
University of Split, School of Medicine 40
Early research (Phase 1)Looking for participantsNCT06950034
What this trial is testing

STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia (CMML)Chronic Myelomonocytic Leukemia-1+9 more
Solu Therapeutics, Inc 105
Early research (Phase 1)WithdrawnNCT03768310
What this trial is testing

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Who this might be right for
Non-hodgkin LymphomaAcute Lymphoblastic Leukemia
Baylor College of Medicine
Post-approval studies (Phase 4)Study completedNCT02078882
What this trial is testing

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
Christopher Bowlus, MD 16
Testing effectiveness (Phase 2)Looking for participantsNCT05564598
What this trial is testing

CMV CTLs in Neonates With CMV Infection

Who this might be right for
Congenital Cytomegaloviral (CMV) Disease
New York Medical College 23
Testing effectiveness (Phase 2)Looking for participantsNCT05184842
What this trial is testing

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Montefiore Medical Center 91
Early research (Phase 1)Active Not RecruitingNCT00840853
What this trial is testing

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma
Baylor College of Medicine 68
Early research (Phase 1)Study completedNCT01109095
What this trial is testing

CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM

Who this might be right for
Glioblastoma Multiforme (GBM)
Baylor College of Medicine 16
Not applicableNot Yet RecruitingNCT07162519
What this trial is testing

Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients

Who this might be right for
Cytotoxic DrugsRomiplostim N01Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 68
Early research (Phase 1)Study completedNCT02670044
What this trial is testing

Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

Who this might be right for
Leukemia, Myeloid, Acute
Hoffmann-La Roche 88